Akums Drugs And Pharmaceuticals Limited Press Release Aug 08 2026
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Akums Drugs and Pharmaceuticals Limited has released its financial results for the first quarter of the fiscal year, highlighting significant revenue growth compared to the previous year. The company reported a notable increase in operating revenue, EBITDA, and profit after tax, driven by strong performance in its Contract Development and Manufacturing Organization business. Management expressed confidence in sustaining growth through operational excellence and a robust pipeline of projects.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Akums Drugs and Pharmaceuticals' latest callAkums Drugs and Pharmaceuticals (NSE:AKUMS) Q2 2027 Earnings Call · Replay · Nov 3Read the transcript of Akums Drugs and Pharmaceuticals (NSE:AKUMS) Q2 2027 Earnings CallAkums Drugs and Pharmaceuticals Limited on 6ix
In the deck
Earlier from Akums Drugs and Pharmaceuticals
- Press Release May 14 2026
- Akums Strengthens European and UK Presence -- India's Largest CDMO Expands Global Footprint
- Press Release Feb 13 2026
- Press Release Nov 13 2025
- Akums Receives ANVISA GMP Certification for Sterile Manufacturing Plant, Expands Global Sterile Manufacturing Footprint
Later from Akums Drugs and Pharmaceuticals
All Akums Drugs and Pharmaceuticals news releasesFollow Akums Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Akums Drugs and Pharmaceuticals